In Ukraine the company “Lumiere Pharma” and MSD (Schering-Plough) have launched a new joint project concerning the production of the innovative preparation UNITRON (PEG-interferon alfa-2b) for the treatment of viral hepatitis.
within the framework of the joint project the preparation UNITRON (PEG-interferon alpha-2b) was registered in Ukraine which is produced from «in bulk» of the company MSD (Schering-Plough) for the treatment of hepatitis B and C in two dosage forms:
- Lyophilized powder for solution for injection in a vial of 50μg/0.5 mL, 80 μg/0.5mL, 100μg/0.5 mL, 120μg/0.5 mL, 150 μg/0.5 ml 5 together with the solvent;
- Lyophilized powder for solution for injection in adual-chamber injection pen (redipen) of 50μg/0.5 mL, 80 μg/0.5mL, 100μg/0.5mL, 120μg/0.5 mL, 150 μg/ 0.5 ml with the solvent.
2 November 2012